SoftBank Vision Fund 2 led a $100m Series C funding round in Biofourmis, a digital therapeutics and personalized predictive care services provider. The round saw participation from existing investors Openspace Ventures, MassMutual Ventures, Sequoia Capital and EDBI. "We believe predictive health is the future of medicine and Biofourmis is a leader in using AI and machine learning-based solutions to advance digital therapeutics. We are excited to partner with Biofourmis and support their mission of using AI and wearables data to enable personalized care," Greg Moon, SoftBank Managing Partner.